Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

A Dispenzieri

Showing results (91-100 of 154) with videos related to

Pageof 16
Sort By:
Leukemia|August 30, 2017
Outcomes of maintenance therapy with lenalidomide or bortezomib in multiple myeloma in the setting of early autologous stem cell transplantationR Chakraborty, E Muchtar, S K Kumar, et al.
Bone Marrow Transplantation|October 12, 2010
Predicting PBSC harvest failure using circulating CD34 levels: developing target-based cutoff points for early interventionS Sinha, D Gastineau, I Micallef, et al.
Blood|September 25, 2001
Translocations involving the immunoglobulin heavy-chain locus are possible early genetic events in patients with primary systemic amyloidosisS R Hayman, R J Bailey, S M Jalal, et al.
Bone Marrow Transplantation|November 26, 2013
Second transplants for multiple myeloma relapsing after a previous autotransplant-reduced-intensity allogeneic vs autologous transplantationC O Freytes, D H Vesole, J LeRademacher, et al.
Bone Marrow Transplantation|September 4, 2003
Effect of thalidomide on stem cell collection and engraftment in patients with multiple myelomaI M Ghobrial, A Dispenzieri, K L Bundy, et al.
Bone Marrow Transplantation|July 15, 2003
Secondary myelodysplastic syndrome and acute myelogenous leukemia are significant complications following autologous stem cell transplantation for lymphomaR Howe, I N M Micallef, D J Inwards, et al.
Bone Marrow Transplantation|July 5, 2016
Autologous stem cell transplant for multiple myeloma patients 70 years or olderE Muchtar, D Dingli, S Kumar, et al.
Leukemia|August 21, 2012
A phase III randomized trial of thalidomide plus zoledronic acid versus zoledronic acid alone in patients with asymptomatic multiple myelomaT E Witzig, K M Laumann, M Q Lacy, et al.
Leukemia|July 12, 2012
Suppression of uninvolved immunoglobulins defined by heavy/light chain pair suppression is a risk factor for progression of MGUSJ A Katzmann, R Clark, R A Kyle, et al.
Blood Cancer Journal|March 21, 2015
Phase I/II study of melphalan, prednisone and lenalidomide combination for patients with newly diagnosed multiple myeloma who are not candidates for stem cell transplantationV Roy, A K Stewart, P L Bergsagel, et al.
Pageof 16

Showing results (91-100 of 154) with videos related to

Sort By:
Pageof 16
Leukemia|August 30, 2017
Outcomes of maintenance therapy with lenalidomide or bortezomib in multiple myeloma in the setting of early autologous stem cell transplantationR Chakraborty, E Muchtar, S K Kumar, et al.
Bone Marrow Transplantation|October 12, 2010
Predicting PBSC harvest failure using circulating CD34 levels: developing target-based cutoff points for early interventionS Sinha, D Gastineau, I Micallef, et al.
Blood|September 25, 2001
Translocations involving the immunoglobulin heavy-chain locus are possible early genetic events in patients with primary systemic amyloidosisS R Hayman, R J Bailey, S M Jalal, et al.
Bone Marrow Transplantation|November 26, 2013
Second transplants for multiple myeloma relapsing after a previous autotransplant-reduced-intensity allogeneic vs autologous transplantationC O Freytes, D H Vesole, J LeRademacher, et al.
Bone Marrow Transplantation|September 4, 2003
Effect of thalidomide on stem cell collection and engraftment in patients with multiple myelomaI M Ghobrial, A Dispenzieri, K L Bundy, et al.
Bone Marrow Transplantation|July 15, 2003
Secondary myelodysplastic syndrome and acute myelogenous leukemia are significant complications following autologous stem cell transplantation for lymphomaR Howe, I N M Micallef, D J Inwards, et al.
Bone Marrow Transplantation|July 5, 2016
Autologous stem cell transplant for multiple myeloma patients 70 years or olderE Muchtar, D Dingli, S Kumar, et al.
Leukemia|August 21, 2012
A phase III randomized trial of thalidomide plus zoledronic acid versus zoledronic acid alone in patients with asymptomatic multiple myelomaT E Witzig, K M Laumann, M Q Lacy, et al.
Leukemia|July 12, 2012
Suppression of uninvolved immunoglobulins defined by heavy/light chain pair suppression is a risk factor for progression of MGUSJ A Katzmann, R Clark, R A Kyle, et al.
Blood Cancer Journal|March 21, 2015
Phase I/II study of melphalan, prednisone and lenalidomide combination for patients with newly diagnosed multiple myeloma who are not candidates for stem cell transplantationV Roy, A K Stewart, P L Bergsagel, et al.
Pageof 16